Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Net Income (2018 - 2025)

AVITA Medical's Net Income history spans 8 years, with the latest figure at -$11.6 million for Q4 2025.

  • For Q4 2025, Net Income fell 123.15% year-over-year to -$11.6 million; the TTM value through Dec 2025 reached -$48.6 million, down 72417.91%, while the annual FY2025 figure was -$48.6 million, 72417.91% down from the prior year.
  • Net Income reached -$11.6 million in Q4 2025 per RCEL's latest filing, up from -$13.2 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $50.2 million in Q4 2024 to a low of -$18.7 million in Q1 2024.
  • Average Net Income over 5 years is -$4.4 million, with a median of -$9.2 million recorded in 2023.
  • Peak YoY movement for Net Income: surged 785.6% in 2023, then plummeted 123.15% in 2025.
  • A 5-year view of Net Income shows it stood at -$5.9 million in 2021, then grew by 7.73% to -$5.5 million in 2022, then soared by 785.6% to $37.6 million in 2023, then soared by 33.39% to $50.2 million in 2024, then crashed by 123.15% to -$11.6 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Net Income are -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025).